Holdings of Lord Abbett Health Care Fund
LORD ABBETT SECURITIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 8.1M $ including 8M $ in equities, 98.2 %
- Positions
- 60 in 11 countries
- Top ten
- 37.6 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 775 | 724.3K $ | 8.89 % |
| 2 | AstraZeneca PLC | 2,029 | 384.9K $ | 4.73 % |
| 3 | Gilead Sciences Inc | 2,647 | 346.3K $ | 4.25 % |
| 4 | Johnson & Johnson | 1,129 | 259.5K $ | 3.19 % |
| 5 | Nektar Therapeutics | 3,038 | 258.4K $ | 3.17 % |
| 6 | Natera Inc | 1,151 | 237.3K $ | 2.91 % |
| 7 | Tarsus Pharmaceuticals Inc | 3,622 | 230.4K $ | 2.83 % |
| 8 | Guardant Health Inc | 2,459 | 214.1K $ | 2.63 % |
| 9 | Argenx SE | 266 | 208.6K $ | 2.56 % |
| 10 | Novartis AG | 1,356 | 200.4K $ | 2.46 % |
| 11 | CVS Health Corp | 2,320 | 193.2K $ | 2.37 % |
| 12 | Madrigal Pharmaceuticals Inc | 350 | 181.1K $ | 2.22 % |
| 13 | Intuitive Surgical Inc | 393 | 179.8K $ | 2.21 % |
| 14 | Cogent Biosciences Inc | 4,983 | 178.3K $ | 2.19 % |
| 15 | Galderma Group AG | 818 | 171.6K $ | 2.11 % |
| 16 | UnitedHealth Group Inc | 461 | 170.8K $ | 2.10 % |
| 17 | Celcuity Inc | 1,349 | 163.7K $ | 2.01 % |
| 18 | Bridgebio Pharma Inc | 2,278 | 162K $ | 1.99 % |
| 19 | Cencora Inc | 525 | 161.7K $ | 1.99 % |
| 20 | Ascendis Pharma A/S | 698 | 160.1K $ | 1.97 % |
| 21 | Abivax SA | 1,296 | 152.1K $ | 1.87 % |
| 22 | Edwards Lifesciences Corp | 1,775 | 148.2K $ | 1.82 % |
| 23 | Mirum Pharmaceuticals Inc | 1,467 | 142.8K $ | 1.75 % |
| 24 | UCB SA | 522 | 142.1K $ | 1.75 % |
| 25 | Dianthus Therapeutics Inc | 1,575 | 138.3K $ | 1.70 % |
| 26 | United Therapeutics Corp | 234 | 133.7K $ | 1.64 % |
| 27 | Vertex Pharmaceuticals Inc | 311 | 132.9K $ | 1.63 % |
| 28 | Thermo Fisher Scientific Inc | 252 | 120.7K $ | 1.48 % |
| 29 | Revolution Medicines Inc | 764 | 110.1K $ | 1.35 % |
| 30 | Teva Pharmaceutical Industries Ltd | 2,957 | 103.7K $ | 1.27 % |
| 31 | Adaptive Biotechnologies Corp | 6,769 | 95.4K $ | 1.17 % |
| 32 | PTC Therapeutics Inc | 1,401 | 91.1K $ | 1.12 % |
| 33 | Insmed Inc | 630 | 85.9K $ | 1.05 % |
| 34 | Mineralys Therapeutics Inc | 3,220 | 85.8K $ | 1.05 % |
| 35 | Otsuka Holdings Co Ltd | 1,162 | 84.7K $ | 1.04 % |
| 36 | CG oncology Inc | 1,223 | 81.6K $ | 1.00 % |
| 37 | BeOne Medicines Ltd | 3,387 | 76.9K $ | 0.94 % |
| 38 | Rhythm Pharmaceuticals Inc | 942 | 76.6K $ | 0.94 % |
| 39 | Glaukos Corp | 526 | 75.6K $ | 0.93 % |
| 40 | Arrowhead Pharmaceuticals Inc | 962 | 70.7K $ | 0.87 % |
| 41 | 10X Genomics Inc | 3,200 | 70.6K $ | 0.87 % |
| 42 | HeartFlow Inc | 2,360 | 70.2K $ | 0.86 % |
| 43 | Encompass Health Corp | 677 | 67.7K $ | 0.83 % |
| 44 | GeneDx Holdings Corp | 1,046 | 65.8K $ | 0.81 % |
| 45 | TransMedics Group Inc | 650 | 65.5K $ | 0.80 % |
| 46 | DBV Technologies SA | 2,973 | 62.4K $ | 0.77 % |
| 47 | Stryker Corp | 186 | 58.6K $ | 0.72 % |
| 48 | Protagonist Therapeutics Inc | 580 | 57.4K $ | 0.70 % |
| 49 | Newamsterdam Pharma Co NV | 1,944 | 55.5K $ | 0.68 % |
| 50 | Alumis Inc | 2,183 | 53.9K $ | 0.66 % |
| 51 | Nuvalent Inc | 520 | 52.1K $ | 0.64 % |
| 52 | Samsung Biologics Co Ltd | 51 | 50.8K $ | 0.62 % |
| 53 | Repligen Corp | 425 | 50.3K $ | 0.62 % |
| 54 | IDEXX Laboratories Inc | 89 | 49.9K $ | 0.61 % |
| 55 | Roivant Sciences Ltd | 1,451 | 41.4K $ | 0.51 % |
| 56 | Oruka Therapeutics Inc | 603 | 41.3K $ | 0.51 % |
| 57 | Apogee Therapeutics Inc | 487 | 40.4K $ | 0.50 % |
| 58 | Scholar Rock Holding Corp | 822 | 38.3K $ | 0.47 % |
| 59 | RadNet Inc | 672 | 38K $ | 0.47 % |
| 60 | ORIC Pharmaceuticals Inc | 3,130 | 30.9K $ | 0.38 % |
Sector breakdown
- Health care 49.3 %
- Unattributed 50.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 83.5 %
- GBP 4.8 %
- CHF 4.7 %
- EUR 4.4 %
- JPY 1.1 %
- HKD 1.0 %
- KRW 0.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 78.3 %
- United Kingdom 4.8 %
- Switzerland 4.7 %
- Belgium 4.4 %
- France 2.7 %
- Israel 1.3 %
- Japan 1.1 %
- Hong Kong SAR China 1.0 %
- Netherlands 0.7 %
- South Korea 0.6 %
- Bermuda 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 47 | 6.3M $ | 78.30 % |
| 2 | United Kingdom | 1 | 384.9K $ | 4.81 % |
| 3 | Switzerland | 2 | 372K $ | 4.65 % |
| 4 | Belgium | 2 | 350.7K $ | 4.39 % |
| 5 | France | 2 | 214.6K $ | 2.68 % |
| 6 | Israel | 1 | 103.7K $ | 1.30 % |
| 7 | Japan | 1 | 84.7K $ | 1.06 % |
| 8 | Hong Kong SAR China | 1 | 76.9K $ | 0.96 % |
| 9 | Netherlands | 1 | 55.5K $ | 0.69 % |
| 10 | South Korea | 1 | 50.8K $ | 0.64 % |
| 11 | Bermuda | 1 | 41.4K $ | 0.52 % |
Cite this page
Titelia. "Holdings of Lord Abbett Health Care Fund". https://titelia.com/en/funds/S000064462